Literature DB >> 21232548

fMRI activation during response inhibition and error processing: the role of the DAT1 gene in typically developing adolescents and those diagnosed with ADHD.

Wouter Braet1, Katherine A Johnson, Claire T Tobin, Ruth Acheson, Caroline McDonnell, Ziarah Hawi, Edwina Barry, Aisling Mulligan, Michael Gill, Mark A Bellgrove, Ian H Robertson, Hugh Garavan.   

Abstract

The DAT1 gene codes for the dopamine transporter, which clears dopamine from the synaptic cleft, and a variant of this gene has previously been associated with compromised response inhibition in both healthy and clinical populations. This variant has also been associated with ADHD, a disorder that is characterised by disturbed dopamine function as well as problems with response inhibition. In the present study we used fMRI to investigate the role of dopaminergic genetic variation on executive functioning by comparing how activation associated with successful and unsuccessful inhibitions differs based on DAT1-genotype and ADHD-diagnosis in adolescents performing a go/nogo task. The results identify regional specificity concerning which functional differences can be attributed to the possession of the high risk DAT1 genotype, the clinical condition or an interaction between the two. During response inhibition, individuals with two copies of the 10-repeat allele showed increased activation in frontal, medial, and parietal regions, which may indicate that inhibition is more effortful for this group. Conversely, this group displayed a reduced error response in the parahippocampal gyrus, suggestive of reduced learning from errors. There were also a number of frontal, parietal, medial and occipital regions, where the relationship between genotype and fMRI-activation differed between the ADHD group and the typically developing adolescents. Finally, the ADHD group displayed decreased activation in parietal and (pre)frontal regions during response inhibition, and in frontal and medial brain regions on error trials.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21232548     DOI: 10.1016/j.neuropsychologia.2011.01.001

Source DB:  PubMed          Journal:  Neuropsychologia        ISSN: 0028-3932            Impact factor:   3.139


  17 in total

Review 1.  Neuropsychopharmacology and neurogenetic aspects of executive functioning: should reward gene polymorphisms constitute a diagnostic tool to identify individuals at risk for impaired judgment?

Authors:  Abdalla Bowirrat; Thomas J H Chen; Marlene Oscar-Berman; Margaret Madigan; Amanda Lh Chen; John A Bailey; Eric R Braverman; Mallory Kerner; John Giordano; Siobhan Morse; B William Downs; Roger L Waite; Frank Fornari; Zaher Armaly; Kenneth Blum
Journal:  Mol Neurobiol       Date:  2012-02-28       Impact factor: 5.590

Review 2.  Applying imaging genetics to ADHD: the promises and the challenges.

Authors:  Zhaomin Wu; Li Yang; Yufeng Wang
Journal:  Mol Neurobiol       Date:  2014-04-01       Impact factor: 5.590

3.  Functional Neuroimaging Evidence for Distinct Neurobiological Pathways in Attention-Deficit/Hyperactivity Disorder.

Authors:  Michael C Stevens; Godfrey D Pearlson; Vince D Calhoun; Katie L Bessette
Journal:  Biol Psychiatry Cogn Neurosci Neuroimaging       Date:  2017-09-23

Review 4.  Genetic targeting of the amphetamine and methylphenidate-sensitive dopamine transporter: on the path to an animal model of attention-deficit hyperactivity disorder.

Authors:  Marc A Mergy; Raajaram Gowrishankar; Gwynne L Davis; Tammy N Jessen; Jane Wright; Gregg D Stanwood; Maureen K Hahn; Randy D Blakely
Journal:  Neurochem Int       Date:  2013-12-08       Impact factor: 3.921

Review 5.  Imaging genetics in neurodevelopmental psychopathology.

Authors:  Marieke Klein; Marjolein van Donkelaar; Ellen Verhoef; Barbara Franke
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2017-07       Impact factor: 3.568

6.  Testing differential susceptibility: Plasticity genes, the social environment, and their interplay in adolescent response inhibition.

Authors:  Jennifer S Richards; Alejandro Arias Vásquez; Daan van Rooij; Dennis van der Meer; Barbara Franke; Pieter J Hoekstra; Dirk J Heslenfeld; Jaap Oosterlaan; Stephen V Faraone; Catharina A Hartman; Jan K Buitelaar
Journal:  World J Biol Psychiatry       Date:  2016-05-12       Impact factor: 4.132

Review 7.  Biomarkers in the diagnosis of ADHD--promising directions.

Authors:  Stephen V Faraone; Cristian Bonvicini; Catia Scassellati
Journal:  Curr Psychiatry Rep       Date:  2014-11       Impact factor: 5.285

8.  Neuroimaging Risk Markers for Substance Abuse: Recent Findings on Inhibitory Control and Reward System Functioning.

Authors:  Mary M Heitzeg; Lora M Cope; Meghan E Martz; Jillian E Hardee
Journal:  Curr Addict Rep       Date:  2015-06

Review 9.  Developmental imaging genetics: linking dopamine function to adolescent behavior.

Authors:  Aarthi Padmanabhan; Beatriz Luna
Journal:  Brain Cogn       Date:  2013-10-17       Impact factor: 2.310

10.  Convergent neural substrates of inattention in bipolar disorder patients and dopamine transporter-deficient mice using the 5-choice CPT.

Authors:  Jared W Young; Mark A Geyer; Adam L Halberstadt; Jordy van Enkhuizen; Arpi Minassian; Asma Khan; William Perry; Lisa T Eyler
Journal:  Bipolar Disord       Date:  2019-05-28       Impact factor: 6.744

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.